B. Braun Medical Inc. (B. Braun) announced that the US Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) of B. Braun's Perfusor® Space Syringe Infusion Pump, Infusomat® Space Volumetric Infusion Pump, and Outlook® ES Pump systems for use in the "tracheal delivery of continuous nebulized medications into a nebulizer to treat patients of all ages with or suspected of having the Coronavirus Disease 2019 (COVID-19) and to decrease the exposure of healthcare providers (HCP) to such patients during the COVID-19 pandemic."
"This authorization allows for an alternative method to administer continuous nebulized medications to patients who are critically ill with COVID-19, many of whom are on ventilation," said Wes Cetnarowski, MD, Chief Medical Officer and Senior Vice President, Scientific Affairs at B. Braun. "As hospitals struggle to cope with the surge of patients suffering from this deadly disease, this action provides another tool for healthcare professionals on the front line to treat some of the most serious cases while helping to protect clinicians by reducing their exposure to infected patients."
Studies have shown that using infusion pumps with nebulizers can help provide steady, controlled delivery of nebulized medication to patients with acute respiratory distress syndrome (ARDS). Some of the most critical COVID-19 patients suffer from severe ARDS.
"We applaud this decisive action taken by the FDA to help some of the most seriously ill COVID-19 patients," said Jean-Claude Dubacher, Chairman and Chief Executive Officer of B. Braun Medical Inc. "The rapid review and authorization of this and other COVID-19 countermeasures demonstrate the agency's commitment to ensure that healthcare providers have the medical devices and treatments they need to fight this disease."
The EUA also authorizes ground medical transport use of the Infusomat® Space Volumetric Infusion Pump System. The Perfusor® Space Syringe Infusion Pump System is already cleared for ground transport.
B. Braun submitted the EUA request to FDA on April 8, 2020 under the agency's January 2017 "Guidance for Emergency Use Authorization of Medical Products and Related Authorities," which enhances FDA's authority to support emergency preparedness and response and foster the development and availability of medical products for use in public health emergencies.
Aware of her elements, Neha writes the best articles across industries including electronics & semiconductors, automotive & transportation and food & beverages. Being from the finance background she has the ability to understand the dynamics of every industry and analyze the news updates to form insightful articles. Neha is an energetic person interested in music, travel, and entertainment. Since past 5 years, she written extensively on sectors like technology, finance and healthcare.
Smarter Decisions with Smart News
Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.